INPX yields 3795.07% · PFE yields 6.13%● Live data
📍 INPX pulled ahead of the other in Year 1
Combined, INPX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INPX + PFE for your $10,000?
Inpixon, together with its subsidiaries, provides solutions and technologies worldwide. The company operated through three segments: Indoor Intelligence, Saves, and Shoom. The Indoor Intelligence segment offers smart office app provide a frictionless work environment; executive briefing centers, an omni-channel software platform provides a virtual briefing platform allowing organizations to offer a personalized experience for in-office, remote, and hybrid meetings; events, offers a mobile first and virtual event platform to connect remote and in person audiences in a fully branded, end to end event experience; inpixon mapping solution which provides users with the tools to add intelligence to complex indoor spaces; augmented reality and 3D allow businesses to scan a space and attach AR content persistently to any position; analytics and insights, a cloud-based analytics platform allows data from multiple sensors and data sources to be visualized for action by the operator; and on-device positioning solution enables a smartphone's precise location to be displayed to a user in a mobile app. This segment also provides Internet of Things (IoT) software-as-a-service platform, IoT devices, sensors and tags, video integration, security, and transceiver/modules. The Shoom segment offers digital solutions or cloud-based applications and analytics for the media and publishing industry, including eTearsheets and eInvoice. The SAVES provides a set of data analytics and statistical visualization software solutions for engineers and scientists, as well as data analytics and statistical visualization tools which comprise SigmaPlot, SigmaStat, SYSTAT, PeakFit, TableCurve 2D, TableCurve 3D, SigmaScan and MYSTAT. The company was formerly known as Sysorex Global and changed its name to Inpixon in March 2017. Inpixon is headquartered in Palo Alto, California.
Full INPX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.